We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RADLY market cap is 7.13B. The company's latest EPS is BRL 0.6141 and P/E is 42.81.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 18.47B | 21.18B | 25.61B | 30.95B | 36.35B |
| Operating Income | 1.12B | 927.18M | 1.37B | 1.84B | 2.08B |
| Net Income | 772.24M | 484.44M | 751.93M | 996.11M | 1.05B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 12.25B | 13.83B | 14.78B | 17.19B | 20.09B |
| Total Liabilities | 8.17B | 9.4B | 10.06B | 11.78B | 14.07B |
| Total Equity | 4.08B | 4.43B | 4.72B | 5.4B | 6.03B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 965.21M | 1.48B | 1.55B | 1.68B | 1.79B |
| Investing | -2.74M | -673.1M | -885.95M | -1.23B | -1.31B |
| Financing | -904.81M | -223.01M | -1.19B | -375.25M | -499.42M |
| Market Cap | 7.13B |
| Price to Earnings Ratio | 42.81 |
| Price to Sales Ratio | 1.24 |
| Price to Cash Ratio | 109.54 |
| Price to Book Ratio | 7.49 |
| Dividend Yield | 6.69% |
| Shares Outstanding | 1.72B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.85 (17.14%) |
| Company Name | Raia Drogasil Sa (PK) |
| Address |
av. corifeu de azevedo marques 3.097 bairro butanta sao paulo, sao paulo 05339-900 |
| Website | https://www.drogasil.com.br |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
